87
Views
0
CrossRef citations to date
0
Altmetric
Original Investigations

Serum proteomics analysis of drug-naïve patients with generalised anxiety disorder: Tandem mass tags and multiple reaction monitoring

ORCID Icon, , , , , , , , & show all
Pages 188-199 | Received 28 Aug 2023, Accepted 28 Dec 2023, Published online: 21 Jan 2024

References

  • Afridi R, Seol S, Kang HJ, Suk K. 2021. Brain-immune interactions in neuropsychiatric disorders: lessons from transcriptome studies for molecular targeting. Biochem Pharmacol. 188:114532. doi: 10.1016/j.bcp.2021.114532.
  • Armbrecht E, Shah R, Poorman GW, Luo L, Stephens JM, Li B, Pappadopulos E, Haider S, McIntyre RS. 2021. Economic and humanistic burden associated with depression and anxiety among adults with non-communicable chronic diseases (NCCDs) in the United States. J Multidiscip Healthc. 14:887–896. doi: 10.2147/JMDH.S280200.
  • Arosio P, Ingrassia R, Cavadini P. 2009. Ferritins: a family of molecules for iron storage, antioxidation and more. Biochim Biophys Acta. 1790(7):589–599. doi: 10.1016/j.bbagen.2008.09.004.
  • Bavbek N, Yilmaz H, Erdemli HK, Selcuki Y, Duranay M, Akçay A. 2014. Correlation between iron stores and QTc dispersion in chronic ambulatory peritoneal dialysis patients. Ren Fail. 36(2):187–190. doi: 10.3109/0886022X.2013.836750.
  • Beaufort N, Scharrer E, Kremmer E, Lux V, Ehrmann M, Huber R, Houlden H, Werring D, Haffner C, Dichgans M. 2014. Cerebral small vessel disease-related protease HtrA1 processes latent TGF-β binding protein 1 and facilitates TGF-β signaling. Proc Natl Acad Sci USA. 111(46):16496–16501. doi: 10.1073/pnas.1418087111.
  • Biswas S, Sharma S, Saroha A, Bhakuni DS, Malhotra R, Zahur M, Oellerich M, Das HR, Asif AR. 2013. Identification of novel autoantigen in the synovial fluid of rheumatoid arthritis patients using an immunoproteomics approach. PLOS One. 8(2):e56246. doi: 10.1371/journal.pone.0056246.
  • Buscemi L, Ramonet D, Klingberg F, Formey A, Smith-Clerc J, Meister JJ, Hinz B. 2011. The single-molecule mechanics of the latent TGF-β1 complex. Curr Biol. 21(24):2046–2054. doi: 10.1016/j.cub.2011.11.037.
  • Canales NA, Marina VM, Castro JS, Jiménez AA, Mendoza-Hernández G, Mc CE, Roman MB, Castro-Romero JI. 2014. A1BG and C3 are overexpressed in patients with cervical intraepithelial neoplasia III. Oncol Lett. 8(2):939–947. doi: 10.3892/ol.2014.2195.
  • Capuron L, Miller AH. 2011. Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther. 130(2):226–238. doi: 10.1016/j.pharmthera.2011.01.014.
  • Caraci F, Spampinato SF, Morgese MG, Tascedda F, Salluzzo MG, Giambirtone MC, Caruso G, Munafò A, Torrisi SA, Leggio GM, et al. 2018. Neurobiological links between depression and AD: the role of TGF-β1 signaling as a new pharmacological target. Pharmacol Res. 130:374–384. doi: 10.1016/j.phrs.2018.02.007.
  • Chen Q, Yang Y, Hou J, Shu Q, Yin Y, Fu W, Han F, Hou T, Zeng C, Nemeth E, et al. 2019. Increased gene copy number of DEFA1/DEFA3 worsens sepsis by inducing endothelial pyroptosis. Proc Natl Acad Sci U S A. 116(8):3161–3170. doi: 10.1073/pnas.1812947116.
  • Costello H, Gould RL, Abrol E, Howard R. 2019. Systematic review and meta-analysis of the association between peripheral inflammatory cytokines and generalised anxiety disorder. BMJ Open. 9(7):e027925. doi: 10.1136/bmjopen-2018-027925.
  • Dobolyi A, Palkovits M. 2008. Expression of latent transforming growth factor beta binding proteins in the rat brain. J Comp Neurol. 507(3):1393–1408. doi: 10.1002/cne.21621.
  • Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctôt KL. 2010. A meta-analysis of cytokines in major depression. Biol Psychiatry. 67(5):446–457. doi: 10.1016/j.biopsych.2009.09.033.
  • Druart M, Nosten-Bertrand M, Poll S, Crux S, Nebeling F, Delhaye C, Dubois Y, Mittag M, Leboyer M, Tamouza R, et al. 2021. Elevated expression of complement C4 in the mouse prefrontal cortex causes schizophrenia-associated phenotypes. Mol Psychiatry. 26(7):3489–3501. doi: 10.1038/s41380-021-01081-6.
  • Eskandari F, Webster JI, Sternberg EM. 2003. Neural immune pathways and their connection to inflammatory diseases. Arthritis Res Ther. 5(6):251–265. doi: 10.1186/ar1002.
  • Felger JC. 2019. Role of inflammation in depression and treatment implications. Handb Exp Pharmacol. 250:255–286.
  • Fu Y, Wu Z, Guo Z, Chen L, Ma Y, Wang Z, Xiao W, Wang Y. 2020. Systems-level analysis identifies key regulators driving epileptogenesis in temporal lobe epilepsy. Genomics. 112(2):1768–1780. doi: 10.1016/j.ygeno.2019.09.020.
  • Gu Z, Eils R, Schlesner M. 2016. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics. 32(18):2847–2849. doi: 10.1093/bioinformatics/btw313.
  • Hatzimanolis A, Foteli S, Stefanatou P, Ntigrintaki AA, Ralli I, Kollias K, Nikolaou C, Gazouli M, Stefanis NC. 2022. Deregulation of complement components C4A and CSMD1 peripheral expression in first-episode psychosis and links to cognitive ability. Eur Arch Psychiatry Clin Neurosci. 272(7):1219–1228. doi: 10.1007/s00406-022-01409-5.
  • He K, Wang Q, Chen J, Li T, Li Z, Li W, Wen Z, Qiang Y, Wang M, Shen J, et al. 2014. ITIH family genes confer risk to schizophrenia and major depressive disorder in the Han Chinese population. Prog Neuropsychopharmacol Biol Psychiatry. 51:34–38. doi: 10.1016/j.pnpbp.2013.12.004.
  • Hou R, Baldwin DS. 2012. A neuroimmunological perspective on anxiety disorders. Hum Psychopharmacol. 27(1):6–14. doi: 10.1002/hup.1259.
  • Hou R, Garner M, Holmes C, Osmond C, Teeling J, Lau L, Baldwin DS. 2017. Peripheral inflammatory cytokines and immune balance in generalised anxiety disorder: case-controlled study. Brain Behav Immun. 62:212–218. doi: 10.1016/j.bbi.2017.01.021.
  • Ishioka N, Takahashi N, Putnam FW. 1986. Amino acid sequence of human plasma alpha 1B-glycoprotein: homology to the immunoglobulin supergene family. Proc Natl Acad Sci U S A. 83(8):2363–2367. doi: 10.1073/pnas.83.8.2363.
  • Kaartinen MT, Arora M, Heinonen S, Hang A, Barry A, Lundbom J, Hakkarainen A, Lundholm N, Rissanen A, Kaprio J, et al. 2021. F13A1 transglutaminase expression in human adipose tissue increases in acquired excess weight and associates with inflammatory status of adipocytes. Int J Obes. 45(3):577–587. doi: 10.1038/s41366-020-00722-0.
  • Kassambara A, Mundt F. 2017. Factoextra: extract and visualize the results of multivariate data analyses. R Package. 76:337–354. https://rpkgs.datanovia.com/factoextra/
  • Kell DB, Pretorius E. 2014. Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells. Metallomics. 6(4):748–773. doi: 10.1039/c3mt00347g.
  • Kim H, Rhee SJ, Lee H, Han D, Lee TY, Kim M, Kim EY, Kwon JS, Shin H, Kim H, et al. 2021. Identification of altered protein expression in major depressive disorder and bipolar disorder patients using liquid chromatography-tandem mass spectrometry. Psychiatry Res. 299:113850. doi: 10.1016/j.psychres.2021.113850.
  • Kim SJ, Cox N, Courchesne R, Lord C, Corsello C, Akshoomoff N, Guter S, Leventhal BL, Courchesne E, Cook EH. 2002. Transmission disequilibrium mapping at the serotonin transporter gene (SLC6A4) region in autistic disorder. Mol Psychiatry. 7(3):278–288. doi: 10.1038/sj.mp.4001033.
  • Konnopka A, König H. 2020. Economic burden of anxiety disorders: a systematic review and meta-analysis. Pharmacoeconomics. 38(1):25–37. doi: 10.1007/s40273-019-00849-7.
  • Li D, Zhang L, Yin H, Xu H, Satkoski Trask J, Smith DG, Li Y, Yang M, Zhu Q. 2014. Evolution of primate α and θ defensins revealed by analysis of genomes. Mol Biol Rep. 41(6):3859–3866. doi: 10.1007/s11033-014-3253-z.
  • Li X, Wang X. 2020. Relationships between stroke, depression, generalized anxiety disorder and physical disability: some evidence from the Canadian community health survey-mental health. Psychiatry Res. 290:113074. doi: 10.1016/j.psychres.2020.113074.
  • Melbourne JK, Rosen C, Feiner B, Sharma RP. 2018. C4A mRNA expression in PBMCs predicts the presence and severity of delusions in schizophrenia and bipolar disorder with psychosis. Schizophr Res. 197:321–327. doi: 10.1016/j.schres.2018.01.018.
  • Michopoulos V, Powers A, Gillespie CF, Ressler KJ, Jovanovic T. 2017. Inflammation in fear- and anxiety-based disorders: PTSD, GAD, and beyond. Neuropsychopharmacology. 42(1):254–270. doi: 10.1038/npp.2016.146.
  • NCCMH. 2011. Generalised anxiety disorder in adults management in primary, secondary and community care. Leicester (UK): British Psychological Society.
  • Nesargikar PN, Spiller B, Chavez R. 2012. The complement system: history, pathways, cascade and inhibitors. Eur J Microbiol Immunol (Bp). 2(2):103–111. doi: 10.1556/EuJMI.2.2012.2.2.
  • Pape K, Tamouza R, Leboyer M, Zipp F. 2019. Immunoneuropsychiatry – novel perspectives on brain disorders. Nat Rev Neurol. 15(6):317–328. doi: 10.1038/s41582-019-0174-4.
  • Penninx BW, Pine DS, Holmes EA, Reif A. 2021. Anxiety disorders. Lancet. 397(10277):914–927. doi: 10.1016/S0140-6736(21)00359-7.
  • Purves-Tyson TD, Robinson K, Brown AM, Boerrigter D, Cai HQ, Weissleder C, Owens SJ, Rothmond DA, Shannon Weickert C. 2020. Increased macrophages and C1qA, C3, C4 transcripts in the midbrain of people with schizophrenia. Front Immunol. 11:2020.
  • Rey R, Suaud-Chagny MF, Bohec AL, Dorey JM, d‘Amato T, Tamouza R, Leboyer M. 2020. Overexpression of complement component C4 in the dorsolateral prefrontal cortex, parietal cortex, superior temporal gyrus and associative striatum of patients with schizophrenia. Brain Behav Immun. 90:216–225. doi: 10.1016/j.bbi.2020.08.019.
  • Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. 1998. The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD. J Clin Psychiatry. 59(Suppl 20):22.
  • Shrivastava S, Chelluboina S, Jedge P, Doke P, Palkar S, Mishra AC, Arankalle VA. 2021. Elevated levels of neutrophil activated proteins, alpha-defensins (DEFA1), calprotectin (S100A8/A9) and myeloperoxidase (MPO) are associated with disease severity in COVID-19 patients. Front Cell Infect Microbiol. 11:751232. doi: 10.3389/fcimb.2021.751232.
  • Stein DJ, Scott KM, de Jonge P, Kessler RC. 2017. Epidemiology of anxiety disorders: from surveys to nosology and back. Dialogues Clin Neurosci. 19(2):127–136. doi: 10.31887/DCNS.2017.19.2/dstein.
  • Suszyńska-Zajczyk J, Luczak M, Marczak L, Jakubowski H. 2014. Hyperhomocysteinemia and bleomycin hydrolase modulate the expression of mouse brain proteins involved in neurodegeneration. J Alzheimers Dis. 40(3):713–726. doi: 10.3233/JAD-132033.
  • Tang Z, Ye G, Chen X, Pan M, Fu J, Fu T, Liu Q, Gao Z, Baldwin DS, Hou R. 2018. Peripheral proinflammatory cytokines in Chinese patients with generalised anxiety disorder. J Affect Disord. 225:593–598. doi: 10.1016/j.jad.2017.08.082.
  • Tian M, Cui YZ, Song GH, Zong MJ, Zhou XY, Chen Y, Han JX. 2008. Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients. BMC Cancer. 8(1):241. doi: 10.1186/1471-2407-8-241.
  • Tritschler I, Gramatzki D, Capper D, Mittelbronn M, Meyermann R, Saharinen J, Wick W, Keski-Oja J, Weller M. 2009. Modulation of TGF-beta activity by latent TGF-beta-binding protein 1 in human malignant glioma cells. Int J Cancer. 125(3):530–540. doi: 10.1002/ijc.24443.
  • Wang H, Liu M. 2021. Complement C4, infections, and autoimmune diseases. Front Immunol. 12:694928. doi: 10.3389/fimmu.2021.694928.
  • WHO. 1992. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health Organization.
  • Yu G, Wang L-G, Luo X, Chen M, Dall’Olio G, Wei W, Gao C-H. Bioconductor version: Release (3.18). A universal enrichment tool for interpreting omics data’. https://bioconductor.org/packages/release/bioc/html/clusterProfiler.html.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.